#USA #Wellington #NAD+ #CELLg8 #Liposomal Delivery

A Revolutionary Approach to NAD+ Supplementation

A recent study published in the Journal of Applied Natural Medicine has unveiled a groundbreaking method to enhance metabolic health through effective nutritional supplementation. This research, spearheaded by Dr. Emek Blair and his team at CELLg8, explores how a novel liposomal delivery system can successfully elevate levels of Nicotinamide Adenine Dinucleotide (NAD+) within human cells, a feat never before accomplished through oral supplements.

Understanding the Importance of NAD+

NAD+ is a crucial coenzyme in the body, playing a vital role in energy production and maintaining DNA integrity. As people age, the natural decline of NAD+ levels has drawn substantial attention from the scientific community, which has long sought methods to replenish these essential components effectively. Historically, efforts to do so stumbled due to the challenges posed by digestive processes, which often render oral supplements ineffective by the time they reach cellular levels.

Innovative Liposomal Delivery Method

The innovative approach taken by CELLg8 centers on a liposomal encapsulation technique specifically designed to preserve the delicate NAD+ molecule. This method allows NAD+ to bypass gastric degradation and deliver it directly to where it is needed most—inside the cells—without relying on the body to convert precursors into NAD+.

In a non-randomized crossover study involving 14 participants, researchers observed unprecedented outcomes. After just two weeks of supplementation, participants experienced an average increase of over 64% in their intracellular NAD+ levels. This result is particularly significant as it marks the first known instance of directly boosting NAD+ levels within cells rather than merely measuring blood plasma concentrations.

Groundbreaking Results Confirm Effectiveness

One of the most critical outcomes of this study is the confirmation of direct cellular impact. The analysis not only highlights the increases in NAD+ levels but also indicates that the liposomal delivery method demonstrates superior bioavailability when compared to traditional nicotinamide supplements. With these promising results, the CELLg8 team believes this study could foreshadow a paradigm shift in how NAD+ supplementation is approached in both personal health and clinical settings.

Dr. Blair emphasized the significance of these findings, stating, “This study is a milestone. By utilizing advanced liposomal technology, we've achieved the best performance in delivering NAD+ directly into the cells to support longevity and energy.” The research results suggest a viable, non-invasive alternative to more traditional methods, like IV drips, for NAD+ replenishment, making it more accessible to the general public.

Implications for Healthy Aging

The introduction of this validated, non-invasive alternative has the potential to change clinical protocols by promoting better efficiency in biological health support. As cellular optimization becomes more readily available, individuals can take proactive measures toward maintaining their health and vitality as they age.

CELLg8, the company leading this innovation, is based in Wellington, Colorado. As a supplement contract manufacturer specializing in novel drug delivery techniques, it aims to enhance nutrient bioavailability to facilitate improved health outcomes through rigorous scientific validation. The successful incorporation of liposomal technology in the realm of NAD+ supplementation paints an optimistic future for health enthusiasts aiming to maintain their vitality and youthfulness.

With the emergence of this type of research and development, the landscape of dietary supplements is likely to undergo substantial changes, offering individuals new avenues to achieve their health goals, supporting their longevity and overall well-being.